Talk:Beta2-adrenergic agonist

From Wikipedia, the free encyclopedia
Jump to: navigation, search
WikiProject Pharmacology (Rated Start-class, Top-importance)
WikiProject icon This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.
Start-Class article Start  This article has been rated as Start-Class on the project's quality scale.
 Top  This article has been rated as Top-importance on the project's importance scale.

There are studies that show asthma drugs (not sure which) will enlarge the muscles in the heart resulting in increased risk for heart attacks. —Preceding unsigned comment added by (talk) 17:03, 20 April 2010 (UTC)


Salbutamol is listed as albuterol. Both names are correct but albuterol is not really recognised outside of the USA. Salbutamol is the International Nonproprietary Name. Moley.mole1 (talk) 15:09, 25 March 2010 (UTC)

Section 'Risks': 2nd paragraph quote of reference 1 is an incorrect corruption of the source by addition of drugs and brand names not mentioned there, particularly "Fluticasone/salmeterol [Serevent, Advair]". Fluticasone is a corticosteroid and should not be mentioned in this list of B2-agonists. Advair is a brand of fluticasone/salmeterol mix but Serevent is a brand of salmeterol only and an example for the given context. Suggest installing the quote properly and following with examples and their brand names/trade names. The mode of writing is confusing: 1)there is inconsistency of non-captialisation for generic drug name to distinguish from trade name, eg salbutamol should not be capitalised; 2) the use of '/' is sometimes used to denoted alternative names but at other times it indicates a mix of two drugs - needs rationalising. (talk) 05:01, 30 November 2010 (UTC)

Under 'Types': generic name (Trade Name) listing of "salbutamol (Albuterol (US name), Ventolin)" incorrectly suggests that albuterol is a trade name when it is an alternative drug name without a capital letter. (talk) 05:01, 30 November 2010 (UTC)

'Trade name' is used but in Australia it is always 'brand name'. Likewise we use drug name or chemical name rather than generic name. How universal is the language used and should there be a minor explanation at least of these differences?


Should Ractopamine be added in this article? Badagnani 17:16, 14 July 2007 (UTC)

Cardiovascular complications[edit]

A single dose of beta2-agonist increases heart rate by 10 BPM. Salpeter et al meta-analysed the data and found more tachycardias and hypokalaemia - unsurprisingly but informatively. PMID 15189956 JFW | T@lk 10:45, 19 December 2007 (UTC)